Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE DE SAINT-EGREVE : revenue, balance sheet and financial ratios

GRANDE PHARMACIE DE SAINT-EGREVE is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-EGREVE (38120), this company of category PME shows in 2025 a net income positive of 240 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE DE SAINT-EGREVE (SIREN 848427910)
Indicator 2025 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C N/C
Net income 240 109 € 278 644 € 348 640 € 357 150 € 314 674 € 58 148 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, GRANDE PHARMACIE DE SAINT-EGREVE generates positive net income of 240 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 58 k€ -> 240 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

240 109 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 97%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

96.519%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

41.308%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

69.8%

Solvency indicators evolution
GRANDE PHARMACIE DE SAINT-EGREVE

Sector positioning

Debt ratio
96.52 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average -8 pts over 3 years

In 2025, the debt ratio of GRANDE PHARMACIE DE SAINT... (96.52) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
41.31% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average

In 2025, the financial autonomy of GRANDE PHARMACIE DE SAINT... (41.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 140.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

140.605

Liquidity indicators evolution
GRANDE PHARMACIE DE SAINT-EGREVE

Sector positioning

Liquidity ratio
140.6 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average -29 pts over 3 years

In 2025, the liquidity ratio of GRANDE PHARMACIE DE SAINT... (140.60) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of GRANDE PHARMACIE DE SAINT-EGREVE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of GRANDE PHARMACIE DE SAINT-EGREVE is estimated at 3 814 159 € (range 2 588 307€ - 5 984 942€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2588k€ 3814k€ 5984k€
3 814 159 € Range: 2 588 307€ - 5 984 942€
NAF 5 année 2025

Valuation method used

Net Income Multiple
240 109 € × 15.9x = 3 814 160 €
Range: 2 588 307€ - 5 984 942€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE DE SAINT-EGREVE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE DE SAINT-EGREVE

What is the revenue of GRANDE PHARMACIE DE SAINT-EGREVE ?

The revenue of GRANDE PHARMACIE DE SAINT-EGREVE is not publicly disclosed (confidential accounts filed with INPI).

Is GRANDE PHARMACIE DE SAINT-EGREVE profitable?

Yes, GRANDE PHARMACIE DE SAINT-EGREVE generated a net profit of 240 k€ in 2025.

Where is the headquarters of GRANDE PHARMACIE DE SAINT-EGREVE ?

The headquarters of GRANDE PHARMACIE DE SAINT-EGREVE is located in SAINT-EGREVE (38120), in the department Isere.

Where to find the tax return of GRANDE PHARMACIE DE SAINT-EGREVE ?

The tax return of GRANDE PHARMACIE DE SAINT-EGREVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE DE SAINT-EGREVE operate?

GRANDE PHARMACIE DE SAINT-EGREVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.